Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults
PHASE2CompletedINTERVENTIONAL
Enrollment
74
Participants
Timeline
Start Date
June 30, 2007
Primary Completion Date
September 30, 2008
Study Completion Date
October 31, 2008
Conditions
Major Depressive Disorder
Interventions
DRUG
Vortioxetine (Lu AA21004)
5 or 10 mg/day; tablets; orally
All Listed Sponsors
lead
H. Lundbeck A/S
INDUSTRY
NCT00761306 - Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults | Biotech Hunter | Biotech Hunter